The giant steps in surgical downsizing toward a personalized treatment of vulvar cancer
- PMID: 34962334
- PMCID: PMC9302990
- DOI: 10.1111/jog.15103
The giant steps in surgical downsizing toward a personalized treatment of vulvar cancer
Abstract
The present article aims to highlight the importance of changes of personalized surgical treatment for vulvar cancer. Current international literature regarding surgical treatment of vulvar cancer was evaluated. This included several studies and systematic reviews. Radical surgery approach, such as en bloc resection, was the first therapeutic option and the standard care for many years, even if burdened with a high complication rate and frequently disfiguring. Taussing and Way introduced radical vulvectomy approach with en bloc bilateral inguinal-femoral lymphadenectomy; modified radical vulvectomy was developed, with a wide radical excision of the primary tumor. The role of inguinofemoral lymphadenectomy (mono or bilateral) changed in the years too, particularly with the advent of SLN biopsy as minimally invasive surgical approach for lymph node staging, in patients with unifocal cancer <4 cm, without suspicious groin nodes. More personalized and conservative surgical approach, consisting of wide local or wide radical excisions, is necessary to reduce complications as lymphedema or sexual disfunction. The optimal surgical management of vulvar cancer needs to consider dimensions, staging, depth of invasion, presence of carcinoma at the surgical margins of resection and grading, with the goal of making the treatment as individualized as possible.
Keywords: Taylor therapy; inguinofemoral lymphadenectomy; radical vulvectomy; sentinel lymph node biopsy; vulvar cancer.
© 2021 The Authors. Journal of Obstetrics and Gynaecology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Obstetrics and Gynecology.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
Similar articles
-
Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy.Gynecol Oncol. 1995 May;57(2):215-20. doi: 10.1006/gyno.1995.1128. Gynecol Oncol. 1995. PMID: 7729737 Clinical Trial.
-
Robot-assisted Sentinel Lymph Node Mapping and Inguinal Lymph Node Dissection Using Near-infrared Fluorescence in Vulvar Cancer.J Minim Invasive Gynecol. 2019 Jul-Aug;26(5):968-972. doi: 10.1016/j.jmig.2019.04.002. Epub 2019 Apr 6. J Minim Invasive Gynecol. 2019. PMID: 30959199
-
Ultrasound-guided FNA cytology of groin lymph nodes improves the management of squamous cell carcinoma of the vulva: Results from a comparative cytohistological study.Cancer Cytopathol. 2019 Aug;127(8):514-520. doi: 10.1002/cncy.22154. Epub 2019 Jun 7. Cancer Cytopathol. 2019. PMID: 31174235
-
Vulvar cancer surgery.Curr Opin Obstet Gynecol. 2014 Feb;26(1):9-17. doi: 10.1097/GCO.0000000000000033. Curr Opin Obstet Gynecol. 2014. PMID: 24270518 Review.
-
Current management of vulvar cancer.Hematol Oncol Clin North Am. 2012 Feb;26(1):45-62. doi: 10.1016/j.hoc.2011.10.006. Hematol Oncol Clin North Am. 2012. PMID: 22244661 Review.
Cited by
-
WNL we never looked: vulvar carcinoma incidence after screening cutoff.Int J Womens Dermatol. 2024 Jan 3;10(1):e127. doi: 10.1097/JW9.0000000000000127. eCollection 2024 Mar. Int J Womens Dermatol. 2024. PMID: 38179153 Free PMC article.
-
Vulvar Hidradenoma Papilliferum.Int J Gen Med. 2024 Feb 26;17:663-667. doi: 10.2147/IJGM.S449102. eCollection 2024. Int J Gen Med. 2024. PMID: 38435116 Free PMC article.
-
Prognostic value of postoperative radiotherapy in patients with vulvar squamous carcinoma: findings based on the SEER database.BMC Womens Health. 2023 Jul 8;23(1):361. doi: 10.1186/s12905-023-02522-w. BMC Womens Health. 2023. PMID: 37420200 Free PMC article.
-
Fatal Progression of Vulvar Cancer in Pregnancy: A Case Report on Delayed Intervention.Am J Case Rep. 2025 Jun 19;26:e947567. doi: 10.12659/AJCR.947567. Am J Case Rep. 2025. PMID: 40534117 Free PMC article.
-
Exploring the potential prompting role of cervical human papilloma virus detection in vulvar lesions: a cross-sectional study in China.Front Oncol. 2024 Feb 15;14:1353580. doi: 10.3389/fonc.2024.1353580. eCollection 2024. Front Oncol. 2024. PMID: 38425337 Free PMC article.
References
-
- Vulvar cancer – cancer stat facts. 2018. [cited Aug 29]. Available from: https://seer.cancer.gov/statfacts/html/vulva.html
-
- Bayne L, Butler J, Colombo N, Geissler J, Green J, Kesic VI, et al. Gynaecological cancers in Europe: facts and figures 2015. ASACO website [cited 2019 May 30].
-
- Greer BE, Koh WJ. New NCCN guidelines for vulvar cancer. J Natl Compr Canc Netw. 2016;14:656–8. - PubMed
-
- Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynaecol Obstet. 2012;119(2):S90–6. - PubMed
-
- Del Pino M, Rodriguez‐Carunchio L, Ordi J. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology. 2013;62(1):161–75. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials